Trial & Ticker

About Trial & Ticker

For more than seven years, I worked as a quantitative researcher developing strategies around small and mid-cap biotech companies. Clinical-trial results can transform these companies overnight. But understanding which trials matter requires connecting trial records, financial filings, drug approvals, company pipelines, competitive landscape and market activity. Existing catalyst calendars are good at answering when an event may happen. I wanted to help answer a different question: How much could this event matter to the stock, and why? That became Trial & Ticker. It ranks upcoming clinical-trial catalysts and explains the individual factors behind every score. The goal is to make serious biotech research easier to understand at a glance. The backtest and research due diligence can be found on the website.

An independent product listed on StarterLaunch. Product details are provided by its maker.